1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine: A Gold-Standard Negative Control for Src Kinase Inhibitor PP 2

Executive Summary: 1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine (CAS No. 5334-30-5) is a small molecule used as a negative control for Src kinase inhibitor PP 2, ensuring high assay specificity in kinase signaling pathway research (APExBIO). It is chemically defined (C₁₁H₉N₅, MW 211.22), DMSO-soluble, and supplied with ≥98% purity (COA/MSDS available). Its use demarcates Src-dependent from non-specific effects in protein tyrosine kinase and cell signaling studies (PS-341.com). This compound is research-use only and not for diagnostic or therapeutic applications. Recent literature clarifies that in vascular studies, Src-kinase inhibitors like PP 2 modulate NADPH oxidase/ROS-driven contraction, but negative controls are essential to validate specificity (Shvetsova et al., 2025).

Biological Rationale

SRC family kinases regulate key cell signaling pathways, including proliferation, migration, and survival (DOI:10.1080/10715762.2024.2448483). Aberrant Src kinase activity is implicated in cancer, vascular disorders, and developmental biology. Chemical inhibitors such as PP 2 target Src activity, but off-target effects can confound interpretation. Negative controls like 1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine allow for precise attribution of observed phenotypes to Src inhibition rather than non-specific compound actions (STATS5 article). This is crucial in translational research, where kinase-driven signaling determines disease models and therapeutic strategies (Elevating Translational Kinase Research—this article expands on strategic use in advanced assay systems).

Mechanism of Action of 1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine

1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine is structurally analogous to PP 2 but lacks Src kinase inhibitory activity (PS-341.com). It does not inhibit protein tyrosine kinases at assay-relevant concentrations (10 μM, DMSO vehicle, 37°C, pH 7.4). When used in parallel with PP 2, it reveals which biological effects are Src-dependent and which are caused by off-target or vehicle-related phenomena. APExBIO supplies this compound at ≥98% purity, ensuring minimal batch variability (product page). It is DMSO-soluble and stable at −20°C. The negative control is not intended to bind or inhibit L-type Ca²⁺ channels, Rho-kinase, or PKC, as confirmed in recent vascular studies (Shvetsova et al., 2025).

Evidence & Benchmarks

• Negative control use enables precise dissection of Src kinase–dependent effects in vascular contraction models, as PP 2 (10 μM) reduces NADPH oxidase/ROS-driven contraction, but 1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine does not (Shvetsova et al., 2025).
• 1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine exhibits no inhibitory activity against protein tyrosine kinases at 10 μM in cell-based and biochemical assays (APExBIO).
• In kinase panel profiling, this compound shows a selectivity index consistent with negative control status: no detectable inhibition of Src, Lck, or Fyn at concentrations up to 10 μM (QC data on COA/MSDS, product page).
• Its use in cancer biology and vascular signaling studies strengthens assay specificity and reduces false positives by discriminating true kinase inhibition from off-target effects (Perylene-Azide article—this article clarifies best practices for cell signaling assays).
• Current consensus recommends matched negative controls in all kinase inhibitor screens to support reproducibility and translational fidelity (PS-341.com—this article details reliability in research use).

Applications, Limits & Misconceptions

This compound is essential for:

• Differentiating Src kinase–dependent from off-target effects in kinase inhibitor studies.
• Validating findings in protein tyrosine kinase inhibition screens.
• Supporting advanced research in cancer biology, vascular signaling, and cell signaling modulation.
• Ensuring specificity in translational and mechanistic signaling pathway research (contrasts prior article by providing new benchmarks in cell signaling specificity).

However, the compound must not be used as a therapeutic agent or for diagnostic procedures. It does not inhibit kinases or other signaling proteins. Its function is to control for non-specific and vehicle effects in assays.

Common Pitfalls or Misconceptions

• Misuse as an Inhibitor: 1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine is not a kinase inhibitor and has no pharmacological action at Src or related kinases.
• Long-Term Solution Storage: Solutions of this compound are unstable and should be used promptly after preparation; storage at −20°C is for the solid form only (APExBIO).
• Diagnostic/Clinical Use: The product is strictly for research use and not for diagnostic or medical applications.
• Non-Specific Control: This compound is a matched negative control for PP 2, not a general control for other kinase inhibitors.
• Misinterpretation of Negative Results: Absence of activity does not confirm assay failure; it confirms specificity when used as intended.

Workflow Integration & Parameters

1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine (SKU: B7190) is supplied as a white to off-white solid at ≥98% purity by APExBIO. It is DMSO-soluble (stock: 10 mM), and best stored at −20°C; shipped with blue ice. Solutions are to be freshly prepared and not stored long-term. Standard assay conditions: 10 μM in DMSO (0.1–1% final), 37°C, pH 7.4. Use in parallel with PP 2 to maximize specificity in kinase signaling studies. Refer to the product page for COA/MSDS and quality control data. For methodical insights on translational assay design, see this article—this article provides updated integration strategies.

Conclusion & Outlook

1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine is a rigorously validated negative control for Src kinase inhibitor PP 2, essential for high-specificity kinase signaling pathway and cell signaling research. Its use ensures that off-target and vehicle effects are accounted for, bolstering assay reliability in cancer biology, vascular, and translational studies. As kinase-driven research advances, such controls remain indispensable for reproducibility and data fidelity. For detailed information and to order, refer to the B7190 kit from APExBIO.